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ABSTRACT
The RNA-recognition motif (RRM) is a common and
evolutionarily conserved RNA-binding module.
Crystallographic and solution structural studies
have shown that RRMs adopt a compact α/β structure, in which four antiparallel β-strands form the
major RNA-binding surface. Conserved aromatic
residues in the RRM are located on the surface of the
β-sheet and are important for RNA binding. To further
our understanding of the structural basis of
RRM-nucleic acid interaction, we carried out a high
resolution analysis of UP1, the N-terminal, two-RRM
domain of heterogeneous nuclear ribonucleoprotein
A1 (hnRNP A1), whose structure was previously
solved at 1.75–1.9 Å resolution. The two RRMs of
hnRNP A1 are closely related but have distinct
functions in regulating alternative pre-mRNA splice
site selection. Our present 1.1 Å resolution crystal
structure reveals that two conserved solvent-exposed
phenylalanines in the first RRM have alternative side
chain conformations. These conformations are
spatially correlated, as the individual amino acids
cannot adopt each of the observed conformations
independently. These phenylalanines are critical for
nucleic acid binding and the observed alternative
side chain conformations may serve as a mechanism
for regulating nucleic acid binding by RRM-containing
proteins.
INTRODUCTION
Human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1)
is an abundant nuclear protein that has been implicated in
many cellular processes, including packaging of nascent RNA
polymerase II transcripts in the nucleus (1,2), regulating alternative 5′ splice site selection in pre-mRNA splicing (3–7),
mediating the splicing-inhibitory effects of certain exonic
splicing silencers (8–11), nuclear–cytoplasm transport (12),
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RNA annealing (13) and telomere length regulation (14). The
protein consists of 320 amino acids and has two RNA-recognition motif (RRM) consensus sequences at the N-terminus,
followed by a glycine-rich C-terminal region. Both the Nterminal domain, known as UP1, and the C-terminal domain
are required for the function of hnRNP A1 in alternative
splicing (15). Furthermore, two functional RRMs are required
for function, as substituting a pair of conserved phenylalanines
in either RRM with a pair of aspartic acids abolishes the
activity of the protein in alternative splicing (15). The two
RRMs of hnRNP A1 are closely related in sequence, yet they
have distinct functions in pre-mRNA splicing. Domain swap
experiments have shown that the alternative splicing function
of hnRNP A1 requires an intact RRM2 at the C-terminal position, whereas the N-terminal RRM can be either RRM1 or
RRM2 (16). Despite lacking the C-terminal domain, UP1
binds efficiently to hnRNP A1 high affinity binding sites determined by SELEX with the intact protein (17) and to singlestranded human telomeric DNA repeats, indicating that the two
RRMs confer the binding specificity and are sufficient for high
affinity binding (14,18–21). The C-terminal domain is capable
of binding RNA independently, but it also engages in
homophilic protein–protein interactions, resulting in cooperative RNA binding, which appears to be important for hnRNP
complex assembly (2) and splicing silencing (8–11). Moreover, the C-terminal domain comprises signals involved in bidirectional nuclear–cytoplasmic transport of hnRNP A1 (22).
The RRM is the most common and best-characterized RNAbinding motif (23,24). RRM-containing proteins have been
found in many pre-mRNA-binding proteins and a host of other
RNA- and single-stranded (ss)DNA-binding proteins in all
three kingdoms of life. The RRM is ∼70–90 amino acids in
length and usually it can be readily identified by its highly
conserved RNP1 octamer and RNP2 hexamer submotifs.
These submotifs consist of characteristic arrays of aromatic
amino acids and a number of interspersed, mostly hydrophobic,
amino acids that are well conserved. The two sequence motifs
are separated by ∼30 amino acids. The three-dimensional
structures of about 20 RRMs have been determined (25). The
RRM structure has a compact, globular α/β-fold. Four
antiparallel β-strands form a consecutive sheet and two
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α-helices are packed on one side of the β-sheet. The exposed
side of the β-sheet is the major RNA-binding surface. In particular,
the conserved RNP1 and RNP2 aromatic residues located in
the two central β-strands are involved in stacking interactions
with the bases of the bound single-stranded nucleic acid.
Though many of the protein–RNA interactions are through
amino acids located on the β-sheet of the RRM core structure,
the specificity for the RNA ligands usually requires residues
outside the conserved structural elements. For example, loops
connecting the β-strands or regions outside the conserved
RRM domain can play prominent roles in RNA recognition
(21,26–28). In addition, many RNA-binding proteins have
multiple RRMs. To date, six structures of proteins with two
tandem RRMs have been determined (21,29–36). The most
notable difference among these structures is the spatial
arrangement of the two RRMs with respect to each other. For
example, the two RRMs in hnRNP A1 are held together by two
pairs of Arg:Asp interactions (35,36), whereas the two RRMs
in the other structures have different and more flexible spatial
arrangements (29–34). Many of the multi-RRM proteins
require contiguous RRMs for binding to their physiological
target sites, and the RRMs act synergistically and function as
an inseparable RNA-binding entity (17,21,37). These observations provide a rationale for how RRM-containing proteins can
bind specifically to a wide spectrum of RNA targets.
Crystallographic and NMR studies have shown that large
conformational changes are often associated with nucleic acid
binding. For example, the loop connecting β2 and β3 in the
N-terminal RRM of U1A exhibits large conformational differences between the apo- and RNA-bound structures (28,38);
upon binding of UP1 to single-stranded telomeric DNA, the
loop connecting the two RRMs becomes ordered and interacts
directly with the ssDNA, and the two RRMs also undergo
moderate movement (21). The domain movement is much
more pronounced in the structure of the RNA-bound sex-lethal
protein (31,33). On the other hand, few conformational
differences between the amino acids in the RNP1 and RNP2
submotifs have been found among all the RRM structures
studied so far, and a similar mode of protein–RNA interaction
involving RNP1 and RNP2 amino acids has been observed for
the various RRMs. It is conceivable, however, that key
residues involved in RNA binding may adopt alternative
conformations, which would suggest a mechanism of
regulating RNA binding or an alternative mode of RNA interaction. For example, such a mechanism may contribute to the
RNA binding and functional differences between two otherwise closely related RRMs, such as those in hnRNP A1.
Nevertheless, all RRM structural analyses carried out to date
have failed to resolve alternative side chain conformations,
possibly due to resolution limits.
Here we report the 1.1 Å crystal structure of the two-RRM
domain (UP1) of hnRNP A1. The crystal structures of UP1 and
its complex with human telomeric ssDNA were previously
determined at lower resolutions (21,35,36). The high resolution
data in the present study allowed us to model alternative side
chain conformations of a number of residues, capturing their
more transient and dynamic conformational states. In particular,
the atomic resolution structure revealed for the first time that
the critical RNA-interacting phenylalanine residues could
undergo concerted conformational changes.

Table 1. Statistics from the crystallographic analysis
Data statistics
No. of observed/
unique reflections

180601/60334

Resolution (Å)

50.00–1.10

Completeness (%)

83.6 (52.0 in the last shell)

Rmerge

0.057 (0.236 in the last shell)

<I/σ>

11.0

Refinement statistics
No. of atoms
(non-hydrogen)

1545 (protein, 1315;
solvent, 230)

R factor

0.146 (F > 4σ)/0.155 (all data)

Rfree

0.185 (F > 4σ)/0.194 (all data)

r.m.s. deviations
bond lengths

0.008 Å

bond angle
distances

0.026 Å

chiral volume
restraints

0.039 Å3

planarity restraints

0.40 Å

main chain atoms

15.8 Å2

side chain atoms

21.9 Å2

solvent atoms

36.2 Å2

Mean B factors

MATERIALS AND METHODS
Data collection and processing
Details of protein production, purification and crystallization
of recombinant human UP1 have been described (39). The
crystals belong to spacegroup P21, with cell constants of
a = 37.71 Å, b = 43.45 Å, c = 55.06 Å and β = 93.7°, and there
is one UP1 molecule per asymmetric unit. Diffraction data
were collected at 100°K on a Brandeis 2 × 2 CCD detector at
the X12C beamline of the National Synchrotron Light Source,
Brookhaven National Laboratory. To collect high resolution
data, the detector to crystal distance was set to 78 mm and the
2θ angle was set to 9.97°. Other parameters used for data
collection were: X-ray wavelength 0.90 Å; oscillation range
0.75° per image; exposure time 3.0 min. Data were processed
using the HKL suite of programs (40) and the data statistics are
shown in Table 1.
Structure refinement
The 1.9 Å crystal structure of UP1 (36) was used as the starting
model for refinement. Several rounds of conventional refinement were first carried out using CNS (41). Anisotropic refinement
was then carried out with SHELXL-97 (42). CNS refinements
were carried out against the scattering amplitudes (Fo) and
SHELXL refinements against the intensities (Fo2). The data
were randomly divided into two sets: a working set composed
of 90% of the data and a test set composed of the remaining
10% for cross-validation purposes. After the refinement was
completed, working and reference data sets were merged and
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used to calculate electron density maps. The programs O (43)
and XtalView (44) were used for model rebuilding with σA and
difference electron density maps. Most of the water molecules
were placed with the help of the program SHELXWAT in
SHELX-97, the rest being placed manually by inspection of
the electron density maps.
The high resolution data allowed us to refine the nonhydrogen atoms anisotropically. The solvent atoms were
restrained to be weakly anisotropic with an estimated standard
deviation of 0.1 Å2. Hydrogen atoms were generated automatically by the program and were included in the refinement
using a riding model (42). Residues Phe17, Phe59 and Val44
exhibited correlated disorder, and this collective behavior was
taken into consideration in the refinement using SHELX-97.
Possible side chain conformations were generated and
included using PART numbers and their occupancies were
treated as free variables and refined using the FVAR and
SUMP commands. Five permissible combinations of Phe17,
Phe59 and Val44 were generated (namely AAA, AAB, AAC,
ABA and BBA, in which the first, second and third letters
denote the conformation of Phe17, Phe59 and Val44, respectively) and each combination was assigned a starting occupancy
value. These occupancy values were treated as free variables in
the refinement, with their sum constrained to be 1. For
example, the occupancy of Phe17 in the A conformation is the
sum of the occupancy values of AAA, AAB, AAC and ABA
and the occupancy (or frequency of appearance) of the
Phe17B/Phe59B/Val44A conformation corresponds to the
value for the BBA combination. The positions and thermal
motions of the relevant conformations (PARTs) were
correlated using the EXYZ and EADP commands. Hydrogen
atoms were not included for these residues. The final model
contains 1315 protein atoms and 230 water molecules. Final R
and Rfree values were 0.155 and 0.194, respectively, for all the
data to 1.1 Å resolution. Figure 1A and B shows the electron
density map around two regions of the protein: (i) amino acids
involved in salt bridges between RRM1 and RRM2 are shown
in Figure 1A; (ii) the conserved RNP1 and RNP2 aromatic
residues of RRM1 are shown in Figure 1B. The maps shown
are σA maps, i.e. (2mFo – DFc) × exp(iαC) maps in which m is
the figure of merit and D is the Luzzati parameter (45). σA
maps were used to minimize model bias. Detailed refinement
statistics are provided in Table 1. The PROCHECK program
(46) was used to check the stereochemical quality of the
refined model. The Ramachandran plots showed that 94.4%
of the residues were in the most favored region and 5.6%
were in the additional allowed region. Figures were
prepared with the program O (43) and structural alignments
were done with the ALIGN program (47).
RESULTS
Overall structure
The refined UP1 structure consists of 163 amino acids
(Lys8–Ser91 and Thr103–Leu181) out of a total of 196 in the
expressed UP1 fragment, plus 230 water molecules. Three
regions were not modeled because of poor electron density: the
first seven residues at the N-terminus, the last 16 residues at the
C-terminus and the internal linker residues Arg92–Leu102.
These regions were disordered in the original 1.75 and 1.9 Å

Figure 1. Electron density maps. (A) A stereo view of the electron density map
showing the Arg:Asp salt bridges that mediate the interactions between RRM1
and RRM2. The amino acids are shown as a stick model. Red, purple and black
colors on the stick model are used to indicate oxygen, nitrogen and carbon
atoms, respectively. Dashed lines indicate salt bridges. The map is a σA map
contoured at the 2σ level. (B) A stereo view of the electron density map showing correlated alternative side chain conformations of Phe17, Phe59 and Val44.
The amino acid side chains are numbered and shown as a stick model. Different side chain conformations are denoted with the suffixes A, B and C, as
described in the text. The electron density map is a σA map contoured at the
1.2σ level.

structures (35,36) and they remained uninterpretable even in
the present high resolution analysis. The linker and many of
the C-terminal residues become ordered when the protein
forms a complex with telomeric ssDNA (21), as they are
involved in direct interaction with the bound single-stranded
oligonucleotide.
UP1 comprises two tandem RNA-binding motifs: RRM1
(amino acids 15–89) and RRM2 (amino acids 106–180). Each
RRM independently adopts the characteristic RRM fold. The
two RRMs share 35% sequence identity and 55% amino acid
similarity (16,21). The root mean square (r.m.s.) deviation
from superimposition of the Cα positions of the two RRMs is
1.37 Å in the present high resolution structure. In our 1.9 Å
resolution structure the r.m.s. deviation was 1.49 Å (36). The
r.m.s. deviation of the Cα positions between the 1.1 and 1.9 Å
structures is 0.177 Å, showing excellent agreement in the
overall structure.
Alternative side chain conformations
The high resolution analysis revealed that six amino acids in
UP1 have alternative side chain conformations. Interestingly,
all six amino acids are located in RRM1. These residues
constitute 3% of the total residues in UP1. The locations of
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these residues (Phe17, Glu24, Gln36, Val44, Phe59 and
Lys78) in the protein are shown in Figure 2.
Three residues are located in loop regions and are exposed to
the solvent: Glu24 in loop 1, Gln36 in loop 2 and Lys78 in loop
5. Although Glu24 and Lys78 are best modeled with alternative side chain conformations, the electron densities for the
alternative conformations are not ideal, suggesting that these
residues have considerable conformational flexibility. Gln36
has a better defined alternative conformational state and it is
located in the vicinity of Phe17′, Phe59′ and Val 44′ (the prime
is used to denote amino acids in a symmetry-related molecule)
(Fig. 3A). The major and minor conformations of Gln36,
designated the A and B conformations, have occupancies of
0.55 and 0.45, respectively. The two conformations are related
by rotations around the Cα–Cβ and Cγ–Cδ bonds. The amide
plane in Gln36A makes edge-on interactions with His33,
Trp37 and Phe59B′. Nε2 of Gln36A interacts with the carbonyl
oxygen of His33 and a water molecule via hydrogen bonds,
and Oε1 of Gln36A hydrogen bonds to another water
molecule. The amide plane of Gln36B makes edge-on interactions with Trp37 and Phe59B′. In addition, Nε2 of Gln36B
contacts Cγ1 of Val44A′/Cγ2 of Val44B′ and Oε1 hydrogen
bonds to a water molecule. The Gln36A conformation is
slightly more preferred, perhaps because it makes ten intramolecular and three intermolecular contacts to other amino
acids and three hydrogen bonds to water molecules. Gln36B
makes nine intramolecular and three intermolecular contacts
with other amino acids and one hydrogen bond to a water
molecule. It appears that other conformations for Gln36 are not
possible in the crystal lattice, because of potential steric
conflicts with neighboring residues, namely Trp37, Phe59′,
Met46′ and Val44′.
The other three multi-conformational residues are located on
the RNA-binding surface: Phe17 on β1, Val44 on β2 and
Phe59 on β3. Phe17 and Phe59 are part of the RNP2 and RNP1
submotifs, respectively. These aromatic residues are highly
conserved among RRMs (23). They interact with RNA or
ssDNA directly in the structure of RRM–RNA and RRM–
ssDNA complexes. In the UP1–TR2 structure (21), in which
TR2 is a ssDNA containing two human telomeric repeats,
(TTAGGG)2, Val44 interacts with G6 via van der Waals interactions and it also forms part of a shallow hydrophobic channel
where TR2 binds. Val44 is not conserved in other RRMs and
the corresponding residues are not always involved in interacting with the nucleic acid. For example, the corresponding
amino acid in the RRM2 of UP1 is Glu135, which does not
interact with TR2 (21).
The side chain of Phe17 has two conformations, denoted
Phe17A and Phe17B (Fig. 3B). Phe17A is the major conformation, with an occupancy of 0.65, Phe17B having an
occupancy of 0.35. The two conformations are related by a
rotation about the Cα–Cβ bond. Both conformers are in hydrophobic environments. Phe17A makes close contacts with
Phe57, Phe59A, the aliphatic portion of Lys87 and the peptide
plane of Gly19. The packing of the phenylalanine rings has a
characteristic edge-on pattern (48) and the peptide plane of
Gly19 is slightly inclined with respect to the Phe17A ring
plane (Fig. 3B). Phe17B contacts Phe59B, Ala89 and the
aliphatic portion of Lys15. Phe17A has a higher occupancy
than Phe17B, possibly because Phe17A makes more intramolecular contacts than does Phe17B: Phe17A makes a total of

Figure 2. A stereo view of the location of residues with alternative side
chain conformations. The Cα chain of RRM1 is shown in blue and the multiconformational side chains are shown in red.

15 intramolecular contacts, while Phe17B makes a total of 12.
On the other hand, the side chain of Phe17B contacts four
water molecules, whereas Phe17A contacts none.
The two side chain conformations of Phe59 have occupancies of 0.57 (Phe59A) and 0.43 (Phe59B) and are related by
a rotation about the Cα–Cβ bond (Fig. 3C). Phe59A contacts
Met46, Phe17A and Phe57. Phe59B contacts Val44A, Asp42,
Thr61, Lys15 and Phe17B. Phe59A makes a total of 14
intramolecular contacts, compared with 11 for Phe59B. An
additional interaction stabilizing the B conformation is
provided by an intermolecular contact with Gln36A′ of a
symmetry-related molecule. Furthermore, Phe59A interacts
with two water molecules, whereas only one such interaction is
found for Phe59B.
There are three possible conformations for valine and all
three conformers are observed for Val44 (Fig. 3C). The three
conformers are denoted Val44A, Val44B and Val44C and they
have occupancies of 0.61, 0.19 and 0.20, respectively. The
high preference for Val44A appears to be due to the existence
of the B conformation of Phe59. Val44A makes a total of eight
intramolecular contacts; two of them are with Phe59B. Val44B
and Val44C each makes five contacts. Both the Val44B and
Val44C conformations are incompatible with the Phe59B
conformation because of steric hindrance. In addition, Val44A
and Val44B each make an intermolecular contact with
Gln36A′. Val44A also contacts two water molecules, while
Val44B and Val44C each contact one water molecule.
Correlated side chain conformations of Phe17, Phe59 and
Val44
Each of the three residues, Phe17, Phe59 and Val44, can adopt
more than one conformation, as described above. However, not
all of the conformations can be independently adopted by these
residues because of potential steric clashes. Permissible
combinations are: (i) Phe17A/Phe59A/Val44A,B,C; (ii)
Phe17A/Phe59B/Val44A; (iii) Phe17B/Phe59B/Val44A (Figs 1B
and 3C). These three combinations have occupancies, or
frequencies of appearance, of 0.57, 0.08 and 0.35, respectively
(see Materials and Methods). The first combination is the same
as that observed in our previous studies (21,36). In the second
combination, Phe17 remains in the major conformation and
Phe59 rotates away from Phe17. Interestingly, this was also
observed in a previous study (35), although this combination is
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Figure 4. Stereo diagram of the superimposition of the two RRMs showing
why the RRM2 phenylalanines cannot adopt the alternative conformations
observed in RRM1. Phe17, Phe59, Val44 (colored purple) and their counterparts in RRM2 (colored red) are shown as a stick model. Three β-strands (β1,
β2 and β3) where these residues are located are also shown with the same color
code. Glu135 in RRM2 is displaced from the corresponding position of Val44
in RRM1, creating clashes if Phe150 adopts the B conformation.

Figure 3. Stereo views showing amino acids with alternative side chain
conformations. Amino acids are shown as sticks. Carbon, nitrogen, oxygen and
sulfur atoms are shown in black, purple, red and green, respectively. (A) Gln36
and its surrounding amino acids. Gln36 has two conformations, Gln36A and
Gln36B, with occupancies of 0.55 and 0.45, respectively. Amino acids from a
neighboring molecule in the crystal lattice are indicated with a prime after the
amino acid number. Red crosses denote water molecules and dashed lines indicate hydrogen bonds. (B) Phe17 and its surrounding amino acids. Phe17 adopts
two conformations, Phe17A and Phe17B, with occupancies of 0.65 and 0.35,
respectively. (C) Phe59, Val44 and their surrounding amino acids. Phe59
adopts two conformations, Phe59A and Phe59B (occupancies of 0.57 and
0.43, respectively). Val44 has three conformations of which only Val44A
(occupancy of 0.61) is labeled. The other two conformations, Val44B and
Val44C, are shown but not labeled. They have similar occupancies and are
related to the A conformation by rotating –120° and 120° around the Cα–Cβ
bond.

not energetically favored due to the absence of interactions
between the two phenylalanines. To avoid steric clashes,
Val44 is forced to adopt the A conformation whenever Phe59
is in the B conformation. In the third combination, the two
phenylalanine residues show a concerted motion, rotating
together away from the major conformation (Figs 1B and 3C). In
this combination Val44 is again restricted to the A conformation.
It is important to keep in mind that Phe17 and Phe59 are key
residues involved in RNA/ssDNA binding. In all the RRM–
nucleic acid complex structures solved so far the phenylalanines are exclusively in the A conformation. It is also clear
that not all RRMs have suitable environments that would allow
the alternative conformations of the phenylalanines observed

here. For example, the corresponding phenylalanines in RRM2
of the present structure (Phe108 and Phe150) do not show
alternative side chain conformations. There are two reasons
that may account for the absence of an alternative side chain
conformation of Phe150. (i) The distance between Phe150 and
Glu135, which corresponds to Val44 in RRM1, is shorter than
that between the corresponding residues in RRM1 (Fig. 4). The
distance between the Cα atoms of Phe150 and Glu135 is 5.08
Å, while it is 5.48 Å between the Cα atoms of Phe59 and
Val44. As a consequence, the Cβ atom of Glu135 is too close
to Phe150 for it to adopt a B conformation similar to Phe59B
(Fig. 4). (ii) A potential B conformation of Phe150 would clash
with the bulky side chain of Glu135, especially the Cδ and Oε1
atoms, in the observed conformation (Fig. 4). Unlike the situation with the Cβ atom, these clashes can be avoided if Glu135
takes an alternative side chain conformation. The alternative
side chain conformations in RRM1 and the absence of alternative
conformations in RRM2 are not due to crystal contacts
because: (i) no crystal contacts were found for Phe17; (ii)
although Phe59B and Val44A/B also interact with Gln36 of a
neighboring molecule, Phe59A and Val44A are the energetically
favored conformations, as reflected by their higher occupancies
compared with the other conformations; (iii) Glu135 is not
involved in crystal contacts. Therefore, crystal contacts cannot
account for the difference in conformational state between
RRM1 and RRM2.
DISCUSSION
The 1.1 Å resolution structure of UP1 presented here shows
that six residues in RRM1 have alternative side chain
conformations. Among these residues, three, Phe17, Phe59 and
Val44, are known to be important for nucleic acid binding.
Interestingly, these alternative conformations of the side
chains are correlated. Spatially correlated side chain disorder,
analogous to that observed in the present structure, was previously reported in the high resolution crystal structure of
crambin (49). In the case of crambin, conformational correlation
of three residues over a range of 8–10 Å has been observed. It
has been suggested that the spatial correlation may have
resulted from short-range (4–8 Å), liquid-like correlated
motion, as revealed in the analysis of diffuse X-ray scattering

1536 Nucleic Acids Research, 2002, Vol. 30, No. 7

Figure 5. Alternative conformations of Phe17 and Phe59 change protein–RNA
interactions. The stereo diagram shows the superimposition of a human telomeric ssDNA (TR2) resembling the high affinity RNA-binding sequence of
hnRNP A1 onto the 1.1 Å resolution structure of UP1. The protein structure is
shown as a ribbon representation (cyan). Phe17, Phe59 and TR2 are shown as
a stick model. Phe17A and Phe59A are shown in cyan; Phe17B and Phe59B
are shown in white and labeled. The color code used for TR2 is red for oxygen,
blue for nitrogen, yellow for carbon and magenta for phosphorus.

of insulin and lysozyme crystals (50,51). The correlated
conformational change observed in the present structure may arise
from similar underlying dynamics. The longest conformational
correlation length in the present UP1 structure is 14.1 Å, which
spans three residues, namely Phe17, Phe59 and Val44, and
corresponds to the distance between the Cγ 2 atom of Val44A/
Cγ1 atom of Val44C and the Cε2 atom of Phe17A.
The corresponding phenylalanines in RRM2 do not show
alternative conformations analogous to those in RRM1. As
mentioned earlier, Phe150 cannot adopt an alternative conformation similar to that of Phe59B because Glu135 is shifted
toward Phe150 by 0.4 Å as compared with the corresponding
Val44 position with respect to Phe59 in RRM1. This difference
between RRM1 and RRM2 is interesting in the context of
hnRNP A1 function in pre-mRNA splicing. Despite the high
sequence conservation and structural similarity between
RRM1 and RRM2 of hnRNP A1, domain swapping and duplication experiments showed that the two RRMs have distinct
functions (16). Efficient alternative splice site switching
activity requires the presence of one copy of RRM2 preceding
the C-terminal glycine-rich domain, whereas the N-terminal
RRM can be either RRM1 or a copy of RRM2 (16). Based on
previous structural results, it has been noted that RRM2 is
necessary to maintain the correct positioning of the two RRMs
via two pairs of salt bridges (21,36). However, restoring the
two salt bridges to the RRM1-duplication variant of hnRNP
A1 is not sufficient for gain of function in alternative splicing,
suggesting that some unique features of RRM1 may interfere
with proper interaction with RNA in the context of alternative
splicing (16). It is possible that the alternative side chain
conformations of the RNA-binding phenylalanines in the
RRM1-duplication variant are incompatible with the type of
RNA binding seen with the wild-type protein.
We previously solved the crystal structure of UP1 bound to
two repeats of human telomeric ssDNA, TTAGGGTTAGGG
(21). Interestingly, in that structure, RRM1 and RRM2 from
two different protein molecules bind to the same strand of
DNA, with each RRM recognizing one of the two telomeric

repeats. This particular mode of binding reflects the high
similarity between the two RRMs and the repetitive nature of
the hnRNP A1 high affinity binding sites in the telomeric
sequence. Nevertheless, truncation derivatives of hnRNP A1
lacking one of the RRMs are still capable of residual RNA
binding and each isolated RRM appears to have unique nucleic
acid-binding properties (16,17,52,53). This difference between
the RRMs can be at least partially attributed to several amino
acids located on their RNA-binding surface. In view of the
findings reported here, alternative side chain conformations
may also contribute to the different properties of RRM1 and
RRM2. Using the structure of the UP1–TR2 complex as a
reference (21), we modeled how UP1 in the Phe17B/Phe59B/
Val44A conformation may bind RNA/ssDNA. We found that
UP1 in this conformation cannot bind TR2 in the same manner
as seen previously (21), because of significant steric clashes
between TR2 and Phe17B/Phe59B (Fig. 5). In particular,
Phe59B is within 2.0 Å of G5 of TR2 and approximately
parallel stacking between Phe17/Phe59 and purine bases is not
maintained. A possible UP1 (Phe17B/Phe59B/Val44A)–TR2
binding mode can be modeled (data not shown), but the path of
the nucleic acid is significantly different from that observed for
UP1 in the standard conformation (21). It is not known at
present whether the UP1 (Phe17B/Phe59B/Val44A)–nucleic
acid interaction occurs in nature. Nevertheless, it can be said
that the alternative side chain conformations would significantly alter the observed mode of nucleic acid binding by
RRM-containing proteins, thus providing a potential
mechanism for regulating RNA binding or perhaps providing
an alternative mode of RNA binding.
We have examined a number of crystal and NMR structures
of RRM-containing proteins to see if any of the aromatic
residues in the RNP1 and RNP2 submotifs also have alternative side chain conformations. Interestingly, the solution
structure of RRM2 of Drosophila sex-lethal protein shows that
Tyr214, which corresponds to Phe17 in UP1, is in a conformation similar to that of Phe17B in UP1 (54). In the crystal
structure of sex-lethal with and without bound RNA, Tyr214
has a conformation similar to that of Phe17A in UP1. Phe256,
which corresponds to Phe59 in UP1, also adopts different
conformations between the NMR and crystal structures.
However, the conformation of Phe256 in the NMR structure of
sex-lethal differs from that of Phe59B in UP1. Therefore, the
second RRM of sex-lethal may also serve as a prototype for
studying the effect of RNA binding due to alternative side
chain conformations of conserved aromatic residues in the
RNP submotifs. Given that the RRM is the most common
RNA-binding motif, it is likely that the observed alternative
side chain conformations of the conserved aromatic residues
also occur in other RRM-containing proteins. In future studies
it will be of interest to determine the effects of alternative side
chain conformation on RNA binding.
Atomic coordinates of the refined model have been deposited with the Protein Data Bank (PDB code 1L3K).
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